Squarepoint’s Cymabay Therapeutics CBAY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-93,133
| Closed | -$2.2M | – | 3076 |
|
|
2023
Q4 | $2.2M | Buy |
93,133
+9,232
| +11% | +$218K | ﹤0.01% | 983 |
|
|
2023
Q3 | $1.25M | Sell |
83,901
-18,232
| -18% | -$272K | ﹤0.01% | 1191 |
|
|
2023
Q2 | $1.12M | Buy |
102,133
+8,251
| +9% | +$90.3K | ﹤0.01% | 1202 |
|
|
2023
Q1 | $819K | Buy |
93,882
+83,855
| +836% | +$731K | ﹤0.01% | 1260 |
|
|
2022
Q4 | $62.9K | Sell |
10,027
-7,468
| -43% | -$46.8K | ﹤0.01% | 2113 |
|
|
2022
Q3 | $61K | Buy |
+17,495
| New | +$61K | ﹤0.01% | 1939 |
|
|
2022
Q1 | – | Sell |
-10,273
| Closed | -$35K | – | 2973 |
|
|
2021
Q4 | $35K | Sell |
10,273
-3,722
| -27% | -$12.7K | ﹤0.01% | 2451 |
|
|
2021
Q3 | $51K | Sell |
13,995
-29,132
| -68% | -$106K | ﹤0.01% | 2106 |
|
|
2021
Q2 | $188K | Sell |
43,127
-21,544
| -33% | -$93.9K | ﹤0.01% | 2260 |
|
|
2021
Q1 | $294K | Sell |
64,671
-88,922
| -58% | -$404K | ﹤0.01% | 1894 |
|
|
2020
Q4 | $882K | Buy |
153,593
+101,092
| +193% | +$581K | 0.01% | 1165 |
|
|
2020
Q3 | $380K | Sell |
52,501
-220,671
| -81% | -$1.6M | 0.01% | 1532 |
|
|
2020
Q2 | $953K | Buy |
273,172
+93,599
| +52% | +$327K | 0.02% | 967 |
|
|
2020
Q1 | $266K | Buy |
179,573
+57,041
| +47% | +$84.5K | 0.01% | 1343 |
|
|
2019
Q4 | $240K | Sell |
122,532
-222,203
| -64% | -$435K | ﹤0.01% | 2065 |
|
|
2019
Q3 | $1.77M | Buy |
+344,735
| New | +$1.77M | 0.02% | 888 |
|
|
2019
Q2 | – | Sell |
-45,195
| Closed | -$600K | – | 2655 |
|
|
2019
Q1 | $600K | Buy |
+45,195
| New | +$600K | 0.01% | 1375 |
|
|
2017
Q4 | – | Sell |
-36,570
| Closed | -$295K | – | 2383 |
|
|
2017
Q3 | $295K | Buy |
36,570
+18,770
| +105% | +$151K | 0.01% | 1174 |
|
|
2017
Q2 | $103K | Sell |
17,800
-13,200
| -43% | -$76.4K | ﹤0.01% | 1396 |
|
|
2017
Q1 | $133K | Buy |
+31,000
| New | +$133K | ﹤0.01% | 1361 |
|